Solid-phase synthesis of succinylhydroxamate peptides: Functionalized matrix metalloproteinase inhibitors

Organic Letters

Volumn 8, Issue 8, 2006, Pages 1705-1708

  Leeuwenburgh, Michiel A ^a   Geurink, Paul P ^a   Klein, Theo ^c   Kauffman, Henk F ^b   Van Der Marel, Gijs A ^a   Bischoff, Rainer ^c   Overkleeft, Herman S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ENZYME INHIBITOR; FLUORESCENT DYE; HYDROXAMIC ACID; METALLOPROTEINASE; PEPTIDE; SUCCINIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; SYNTHESIS;

ADAM PROTEINS; ENZYME INHIBITORS; FLUORESCENT DYES; HYDROXAMIC ACIDS; METALLOENDOPEPTIDASES; MOLECULAR STRUCTURE; PEPTIDES; SUCCINATES;

EID: 33646462137     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol060409e     Document Type: Article

References (23)

1. Johnson, L. J.; Dyer, R.; Hupe, D. J. Curr. Opin. Chem. Biol. 1998, 2, 466-471.
2. (a) Seals, D.; Courtneidge, S. A. Genes Dev. 2003, 17, 7-30.
3. (b) Black, R. A.; White, J. M. Curr. Opin. Cell Biol. 1998, 10, 654-659.
4. Huovila, A.-P. J.; Turner, A. J.; Pelto-Huikko, M.; Kärkkäinen, I.; Ortiz, R. M. Trends Biochem. Sci. 2005, 30, 413-422.
5. For a recent overview, see: Verhelst, S. H. L.; Bogyo, M. QSAR Comb. Sci. 2005, 24, 261-269.
6. Whittaker, M.; Floyd, C. D.; Brown, P.; Gearing, A. J. H. Chem. Rev. 1999, 99, 2735-2776.
7. See, for instance: (a) Mellor, S. L.; McGuire, C.; Chan, W. C. Tetrahedron Lett. 1997, 38, 3311-3314.
8. (b) Sasubilli, R.; Gutheil, W. G. J. Comb. Chem. 2004, 6, 911-915.
9. (c) Gazal, S.; Masterson, L. R.; Barany, G. J. Pept. Res. 2005, 66, 324-332.
10. (d) Yin, Z.; Low, K. S.; Lye, P. L. Synth. Commun. 2005, 35, 2945-2950.
11. Solid-phase strategies of marimastat analogues have been reported: (a) Jenssen, K.; Sewald, K.; Sewald, N. Bioconjugate Chem. 2004, 15, 594-600.
12. (b) Barlaam, B.; Koza, P.; Berriot, J. Tetrahedron 1999, 55, 7221-7232.
13. During the preparation of this manuscript, a paper appeared reporting the synthesis of a library of diastereomeric inhibitors with R = H by using an alternative, racemic building block with O-trityl protection: Wang, J.; Uttamchandani, M.; Sun, L. P.; Yao, S. Q. Chem. Commun. 2006, 717-719.
14. For selected examples of hydroxamate solution syntheses from carboxylic acids, see: (a) Reddy, A. S.; Kumar, M. S.; Reddy, G. R. Tetrahedron Lett. 2000, 41, 6285-6288.
15. (b) Giacomelli, G.; Porcheddu, A.; Salaris, M. Org. Lett. 2003, 5, 2715-2717.
16. For selected examples of hydroxamate solution syntheses from esters, see: (a) Levy, D. E.; Lapierre, F.; Liang, W.; Ye, W.; Lange, C. W.; Li, X.; Grobelny, D.; Casabonne, M.; Tyrrell, D.; Holme, K.; Nadzan, A.; Galardy, R. E. J. Med. Chem. 1998, 41, 199-223.
17. (b) Ho, C. Y.; Strobel, E.; Ralbovsky, J.; Galemmo, R. A., Jr. J. Org. Chem. 2005, 70, 4873-4875.
18. Augé, F.; Hornebeck, W.; Decarme, M.; Laronze, J.-Y. Bioorg. Med. Chem. Lett. 2003, 13, 1783-1786.
19. 3N because the acyl chloride of 3 appeared to be highly sensitive to tertiary amine bases.
20. 2EtN resulted in complete consumption of 7a but also substantial side reactions.
21. Two examples of similar compounds have recently been reported: (a) Saghatelian, A.; Jessani, N.; Joseph, A.; Humphrey, M.; Cravatt, B. F. Proc. Natl. Acad. Sci. 2004, 101, 10000-10005.
22. (b) Chan, E. W. S.; Chattopadhaya, S.; Panicker, R. C.; Huang, X.; Yao, S. Q. J. Am. Chem. Soc. 2004, 126, 14435-14446.
23. Freije, J. R.; Bischoff, R. J. Chromatogr., A 2003, 1009, 155-169.